Alfa Chemistry Newly Introduces Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat
Alfa Chemistry , a leading pharmaceutical supplier, has recently announced the addition of three new API s to its full-ranged product catalog , i.e., tofacitinib citrate, tamoxifen citrate, and epalrestat. The se new products are introduced to meet the growing demands of the pharmaceutical market. Tofacitinib Citrate Tofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by suppressing the immune system and reducing inflammation in the body. Tofacitinib Citrate is a selective inhibitor of Janus kinase (JAK) enzymes, which play a key role in immune response and inflammatory signaling. Alfa Chemistry offers tofacitinib citrate as active pharmaceutical ingredients in various purities and quantities to meet the specific requirements of different research projects. The product is manufactured using advanced technology and under strict quality control procedures to ensure its saf...